3-substituted 1,2,3-triazin-4-one's and 3-substituted 1,3-pyrimidinone's for enhancing glutamatergic synaptic responses

Details for Australian Patent Application No. 2008301884 (hide)

Owner Cortex Pharmaceuticals, Inc.

Inventors Alisala, Kashinatham; Street, Leslie J.; Mueller, Rudolf; Rachwal, Stanislaw

Agent A.P.T. Patent and Trade Mark Attorneys

Pub. Number AU-A-2008301884

PCT Pub. Number WO2009/038752

Priority 60/994,548 20.09.07 US

Filing date 19 September 2008

Wipo publication date 26 March 2009

International Classifications

C07D 255/04 (2006.01) Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups

C07D 239/88 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

8 April 2010 PCT application entered the National Phase

  PCT publication WO2009/038752 Priority application(s): WO2009/038752

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008301888-Long interspersed nuclear element polypeptide compositions and methods of use thereof

2008301873-Weld metal compositions for joining steel structures in the oil and gas industry